Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
Authors:
Open Access
- 1 February 1996
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 15 (3) , 520-527
Abstract
Achondroplasia, the most common genetic form of dwarfism, is an autosomal dominant disorder whose underlying mechanism is a defect in the maturation of the cartilage growth plate of long bones. Achondroplasia has recently been shown to result from a Gly to Arg substitution in the transmembrane domain of the fibroblast growth factor receptor 3 (FGFR3), although the molecular consequences of this mutation have not been investigated. By substituting the transmembrane domain of the Neu receptor tyrosine kinase with the transmembrane domains of wild‐type and mutant FGFR3, the Arg380 mutation in FGFR3 is shown to activate both the kinase and transforming activities of this chimeric receptor. Residues with side chains capable of participating in hydrogen bond formation, including Glu, Asp, and to a lesser extent, Gln, His and Lys, were able to substitute for the activating Arg380 mutation. The Arg380 point mutation also causes ligand‐independent stimulation of the tyrosine kinase activity of FGFR3 itself, and greatly increased constitutive levels of phosphotyrosine on the receptor. These results suggest that the molecular basis of achondroplasia is unregulated signal transduction through FGFR3, which may result in inappropriate cartilage growth plate differentiation and thus abnormal long bone development. Achondroplasia may be one of the number of cogenital disorders where constitutive activation of a member of the FGFR family leads to development abnormalities.Keywords
This publication has 44 references indexed in Scilit:
- SHC and GRB-2 Are Constitutively Activated by an Epidermal Growth Factor Receptor with a Point Mutation in the Transmembrane DomainJournal of Biological Chemistry, 1995
- Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3Nature Genetics, 1995
- Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndromeNature Genetics, 1995
- Localization of the achondroplasia gene to the distal 2. 5 Mb of human chromosome 4pHuman Molecular Genetics, 1994
- Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.Journal of Cell Biology, 1992
- Signal transduction by receptors with tyrosine kinase activityCell, 1990
- Neu receptor dimerizationNature, 1989
- Birth prevalence rates of skeletal dysplasiasClinical Genetics, 1989
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985
- Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine.Journal of Medical Genetics, 1979